Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EXMceuticals Portugal operates a licensed cannabis R&D laboratory and pilot refinery near Lisbon, focusing on phytochemical and cannabinoid/terpene formulations for therapeutic, disinfectant, and cosmeceutical applications; its publicly described work is at pre-clinical and proof‑of‑concept stage with EU‑ and Portugal‑funded projects targeting SARS‑CoV‑2 biocidal disinfectants and topical cosmeceutical/aromatherapy products using cannabis-derived cannabinoids and terpenes.[1][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EXMceuticals Portugal.